The Clinical Alternative to the MoCA Test
The Montreal Cognitive Assessment has been the standard cognitive screening tool for two decades. For many clinical settings — particularly post-acute care, SNFs, and high-volume primary care practices — its 10-15 minute administration time and paper-based format create significant workflow friction. GIA® offers a validated, EHR-integrated alternative that screens in 40 seconds with no added clinician time.
Why Clinicians Are Looking Beyond MoCA
The MoCA was designed as a clinician-administered, paper-based instrument — a format that fits a quiet exam room and a 20-minute slot, but increasingly does not fit the workflow of a busy SNF, an annual wellness visit panel, or a value-based primary care practice. Each screening consumes 10 to 15 minutes of clinician time and produces a paper score sheet that someone has to hand-key into the chart afterward, with no automatic EHR documentation. The MoCA also screens cognition only — it does not surface depression, anxiety, PTSD, or other behavioral health conditions that commonly co-travel with cognitive change. It requires the patient to be physically present with a trained administrator, and copyright restrictions on training and use have tightened for some commercial settings. None of this makes the MoCA a poor instrument; it makes it an instrument whose format is mismatched to the volume, multidisciplinary breadth, and documentation expectations of modern clinical environments.
How GIA® Compares
| MoCA | GIA® | |
|---|---|---|
| Administration time | 10–15 minutes | 40 seconds |
| Clinician time required | Yes | No |
| EHR integration | No | Yes, automatic |
| Conditions screened | Cognitive only | 46 conditions |
| Behavioral health | No | Yes |
| Device required | Paper | Phone or landline |
| Languages | Limited | 92 |
| Validation | Extensive | 19 peer-reviewed studies |
Listed on PointClickCare Marketplace →
Clinical Validation
GIA® has been validated across 19 peer-reviewed studies by independent researchers at Beth Israel Deaconess Medical Center, NIH, and MIT, drawing on a dataset of 12.3M+ patients and 27B+ clinical records. Published AUC for cognitive decline is 0.890, with additional figures for depression (0.816), PTSD (0.800), anxiety (0.775), and Parkinson’s disease (0.97). GIA® is produced by an FDA-registered medical device establishment.
Peer-reviewed AI voice biomarker research published in The Lancet Regional Health — Western Pacific reports AUC scores of 0.88–0.89 for MCI detection — versus the MoCA’s pooled AUC of 0.84 for amnestic MCI detection across 55 published studies and 25,756 subjects. This is a cross-study comparison.
GIA® screens. She does not diagnose. A clinician reviews every result.
Who Uses GIA® as a MoCA Alternative
GIA® is deployed across settings where the MoCA’s clinician-time and paper-based format are the binding constraints. Skilled nursing facilities and post-acute care teams use GIA® for high-volume screening at admission and during stay, with results writing back to PointClickCare and the MDS. Primary care practices use GIA® for the cognitive screening component of the Annual Wellness Visit. Geriatrics practices, neurology clinics, PACE programs, and value-based care organizations use GIA® to standardize screening across panels where consistent, documented, multi-condition screening is more useful than a single cognitive score.
Frequently Asked Questions
Is GIA® a replacement for the MoCA test?
GIA® is not a replacement for clinical judgment — it is a screening tool that identifies which patients need further evaluation. Where the MoCA requires 10-15 minutes of clinician-administered testing, GIA® completes a 40-second natural conversation and delivers results to the EHR in under 2 minutes. GIA® screens. She does not diagnose.
How long does a MoCA test take?
The MoCA typically takes 10-15 minutes to administer. GIA® completes screening in 40 seconds with results available in under 2 minutes.
What are the disadvantages of the MoCA test?
The MoCA requires 10-15 minutes of clinician-administered testing, paper-based recording, and physical presence. It screens for cognitive impairment only — it does not assess behavioral health conditions such as depression, anxiety, or PTSD. It has no native EHR integration and copyright restrictions limit its free use in some commercial settings.
Does GIA® require a trained clinician to administer?
No. GIA® is administered through a natural conversation via phone, video, or landline. No clinician time is required for administration. A clinician reviews every result.
Can GIA® screen for conditions beyond cognitive impairment?
Yes. GIA® screens for 46 cognitive, behavioral, and neurological conditions including depression, anxiety, PTSD, Parkinson's disease, and cognitive decline. The MoCA screens for cognitive impairment only.
Is GIA® validated for use as a MoCA alternative?
GIA® is validated across 19 peer-reviewed studies by independent researchers at Beth Israel Deaconess Medical Center, NIH, and MIT, across a dataset of 12.3M+ patients and 27B+ clinical records.
Does GIA® integrate with EHR systems?
Yes. GIA® results are written directly to the EHR in under 2 minutes. Integrations include PointClickCare, Epic, Cerner, and MatrixCare.
Can GIA® be used in nursing homes and post-acute care settings?
Yes. GIA® was designed with post-acute care as a primary deployment setting. It works via standard phone or landline — no tablet, app, or device required.
Featured in McKnight's Long-Term Care News →
Related Reading
GIA® vs MoCA — full comparison →
AI cognitive screening explained →
Early cognitive decline screening →
Annual Wellness Visit cognitive screening →